Bleakley Financial Group LLC Purchases 9,988 Shares of Clover Health Investments, Corp. (NASDAQ:CLOV)

Bleakley Financial Group LLC lifted its position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) by 98.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,090 shares of the company’s stock after purchasing an additional 9,988 shares during the period. Bleakley Financial Group LLC’s holdings in Clover Health Investments were worth $57,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. Jupiter Asset Management Ltd. grew its position in Clover Health Investments by 18.1% during the first quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock worth $3,593,000 after buying an additional 692,878 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Clover Health Investments in the 2nd quarter valued at $932,000. AQR Capital Management LLC boosted its holdings in shares of Clover Health Investments by 4.6% in the 2nd quarter. AQR Capital Management LLC now owns 729,706 shares of the company’s stock valued at $898,000 after purchasing an additional 32,288 shares in the last quarter. Choreo LLC acquired a new stake in shares of Clover Health Investments in the 2nd quarter valued at $344,000. Finally, Bayesian Capital Management LP acquired a new stake in shares of Clover Health Investments in the 1st quarter valued at $142,000. Institutional investors own 19.77% of the company’s stock.

Clover Health Investments Stock Up 0.3 %

Shares of NASDAQ:CLOV opened at $3.79 on Friday. The firm has a market cap of $1.88 billion, a P/E ratio of -11.15 and a beta of 2.13. Clover Health Investments, Corp. has a 12-month low of $0.61 and a 12-month high of $4.71. The business has a fifty day simple moving average of $3.25 and a 200 day simple moving average of $1.90.

Clover Health Investments (NASDAQ:CLOV) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.05. Clover Health Investments had a negative return on equity of 36.55% and a negative net margin of 7.30%. The firm had revenue of $356.26 million during the quarter, compared to analyst estimates of $338.70 million. During the same period last year, the company posted ($0.06) EPS. As a group, equities research analysts expect that Clover Health Investments, Corp. will post -0.13 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, UBS Group began coverage on Clover Health Investments in a report on Monday, October 7th. They issued a “neutral” rating and a $4.00 target price on the stock.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.